Sustained nitric oxide production in macrophages requires the arginine transporter CAT2

被引:190
作者
Nicholson, B
Manner, CK
Kleeman, J
MacLeod, CL
机构
[1] Univ Calif San Diego, Ctr Canc, La Jolla, CA 92093 USA
[2] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA
关键词
D O I
10.1074/jbc.M010030200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aberrant production of nitric oxide (NO) contributes to the pathogenesis of diseases as diverse as cancer and arthritis. Sustained NO production via the inducible enzyme, nitric-oxide synthase 2 (NOS2), requires extracellular arginine uptake. Three closely related cationic amino acid transporter genes (Cat1-3) encode the transporters that mediate most arginine uptake in mammalian cells. Because CAT2 is induced coordinately with NOS2 in numerous cell types, we investigated a possible role for CAT2-mediated arginine transport in regulating NO production. The complexity of arginine transport systems and their biochemically similar transport properties called for a genetic approach to determine the role of CAT2. CAT2-deficient mice were generated and found to be healthy and fertile in contrast to Cat1(-/-) animals. Analysis of cytokine-activated macrophages from Cat2(-/-) mice revealed a 92% reduction in NO production and a 95% reduction in L-Arg uptake. The reduction in NO production was not due to differences in NOS2 protein expression, NOS2 activity, or intracellular L-arginine content. In conclusion, our results show that sustained abundant NO synthesis by macrophages requires arginine transport via the CAT2 transporter.
引用
收藏
页码:15881 / 15885
页数:5
相关论文
共 35 条
[1]   L-ARGININE TRANSPORT IS INCREASED IN MACROPHAGES GENERATING NITRIC-OXIDE [J].
BOGLE, RG ;
BAYDOUN, AR ;
PEARSON, JD ;
MONCADA, S ;
MANN, GE .
BIOCHEMICAL JOURNAL, 1992, 284 :15-18
[2]  
Closs EI, 2000, MOL PHARMACOL, V57, P68
[3]  
CLOSS EI, 1993, J BIOL CHEM, V268, P7538
[4]  
Closs EI, 1996, AMINO ACIDS, V11, P193, DOI 10.1007/BF00813860
[5]   Deficiency in inducible nitric oxide synthase results in reduced atherosclerosis in apolipoprotein E-deficient mice [J].
Detmers, PA ;
Hernandez, M ;
Mudgett, J ;
Hassing, H ;
Burton, C ;
Mundt, S ;
Chun, S ;
Fletcher, D ;
Card, DJ ;
Lisnock, J ;
Weikel, R ;
Bergstrom, JD ;
Shevell, DE ;
Hermanowski-Vosatka, A ;
Sparrow, CP ;
Chao, YS ;
Rader, DJ ;
Wright, SD ;
Puré, E .
JOURNAL OF IMMUNOLOGY, 2000, 165 (06) :3430-3435
[6]   Transporters for cationic amino acids in animal cells:: Discovery, structure, and function [J].
Devés, R ;
Boyd, CAR .
PHYSIOLOGICAL REVIEWS, 1998, 78 (02) :487-545
[7]   A MAMMALIAN ARGININE LYSINE TRANSPORTER USES MULTIPLE PROMOTERS [J].
FINLEY, KD ;
KAKUDA, DK ;
BARRIEUX, A ;
KLEEMAN, J ;
HUYNH, PD ;
MACLEOD, CL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9378-9382
[8]  
FORTIER AH, 1994, CURRENT PROTOCOLS IM
[9]   Interleukin-1 beta and tumor necrosis factor-alpha stimulate the cat-2 gene of the L-arginine transporter in cultured vascular smooth muscle cells [J].
Gill, DJ ;
Low, BC ;
Grigor, MR .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (19) :11280-11283
[10]  
HIBBS JB, 1987, J IMMUNOL, V138, P550